Literature DB >> 30397898

Histone modification signatures in human sperm distinguish clinical abnormalities.

Samantha B Schon1,2, Lacey J Luense3,4, Xiaoshi Wang4,5, Marisa S Bartolomei3,4, Christos Coutifaris6, Benjamin A Garcia4,5, Shelley L Berger7,8.   

Abstract

PURPOSE: Alternations to the paternal epigenome, specifically the components of sperm chromatin, can lead to infertility in humans and potentially transmit aberrant information to the embryo. One key component of sperm chromatin is the post-translational modification of histones (PTMs). We previously identified a comprehensive profile of histone PTMs in normozoospermic sperm; however, only specific histone PTMs have been identified in abnormal sperm by antibody-based approaches and comprehensive changes to histone PTM profiles remain unknown. Here, we investigate if sperm with abnormalities of total motility, progressive motility, and morphology have altered histone PTM profiles compared to normozoospermic sperm samples.
METHODS: Discarded semen samples from 31 men with normal or abnormal semen parameters were analyzed for relative abundance of PTMs on histone H3 and H4 by "bottom-up" nano-liquid chromatography-tandem mass spectrometry.
RESULTS: Asthenoteratozoospermic samples (abnormal motility, forward progression, and morphology, n = 6) displayed overall decreased H4 acetylation (p = 0.001) as well as alterations in H4K20 (p = 0.003) and H3K9 methylation (p < 0.04) when compared to normozoospermic samples (n = 8). Asthenozoospermic samples (abnormal motility and progression, n = 5) also demonstrated decreased H4 acetylation (p = 0.04) and altered H4K20 (p = 0.005) and H3K9 methylation (p < 0.04). Samples with isolated abnormal progression (n = 6) primarily demonstrated decreased acetylation on H4 (p < 0.02), and teratozoospermic samples (n = 6) appeared similar to normozoospermic samples (n = 8).
CONCLUSION: Sperm samples with combined and isolated abnormalities of total motility, progressive motility, and morphology display distinct and altered histone PTM signatures compared to normozoospermic sperm. This provides evidence that alterations in histone PTMs may be important for normal sperm function and fertility.

Entities:  

Keywords:  Histones; Male infertility; Paternal epigenetics; Post-translational modifications; Sperm

Mesh:

Substances:

Year:  2018        PMID: 30397898      PMCID: PMC6420512          DOI: 10.1007/s10815-018-1354-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  49 in total

1.  A study of semen parameters with emphasis on sperm morphology in a fertile population: an attempt to develop clinical thresholds.

Authors:  S Gunalp; C Onculoglu; T Gurgan; T F Kruger; C J Lombard
Journal:  Hum Reprod       Date:  2001-01       Impact factor: 6.918

2.  Computer-assisted semen analysis parameters as predictors for fertility of men from the general population. The Danish First Pregnancy Planner Study Team.

Authors:  L Larsen; T Scheike; T K Jensen; J P Bonde; E Ernst; N H Hjollund; Y Zhou; N E Skakkebaek; A Giwercman
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

3.  Histone acetylation-mediated chromatin compaction during mouse spermatogenesis.

Authors:  J Govin; C Lestrat; C Caron; C Pivot-Pajot; S Rousseaux; S Khochbin
Journal:  Ernst Schering Res Found Workshop       Date:  2006

4.  Expression of hyperacetylated histone H4 during normal and impaired human spermatogenesis.

Authors:  V Sonnack; K Failing; M Bergmann; K Steger
Journal:  Andrologia       Date:  2002-12       Impact factor: 2.775

5.  Significance of sperm characteristics in the evaluation of male infertility.

Authors:  Kiran P Nallella; Rakesh K Sharma; Nabil Aziz; Ashok Agarwal
Journal:  Fertil Steril       Date:  2006-03       Impact factor: 7.329

6.  Altered protamine 2 expression is uncommon in donors of known fertility, but common among men with poor fertilizing capacity, and may reflect other abnormalities of spermiogenesis.

Authors:  D T Carrell; L Liu
Journal:  J Androl       Date:  2001 Jul-Aug

7.  Controlled comparison of conventional in-vitro fertilization and intracytoplasmic sperm injection in patients with asthenozoospermia.

Authors:  G Verheyen; H Tournaye; C Staessen; A De Vos; M Vandervorst; A Van Steirteghem
Journal:  Hum Reprod       Date:  1999-09       Impact factor: 6.918

8.  Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability.

Authors:  A H Peters; D O'Carroll; H Scherthan; K Mechtler; S Sauer; C Schöfer; K Weipoltshammer; M Pagani; M Lachner; A Kohlmaier; S Opravil; M Doyle; M Sibilia; T Jenuwein
Journal:  Cell       Date:  2001-11-02       Impact factor: 41.582

9.  Sperm nuclear histone to protamine ratio in fertile and infertile men: evidence of heterogeneous subpopulations of spermatozoa in the ejaculate.

Authors:  Xiaoyang Zhang; Maria San Gabriel; Armand Zini
Journal:  J Androl       Date:  2006-02-10

10.  Misregulation of histone acetylation in Sertoli cell-only syndrome and testicular cancer.

Authors:  A K Faure; C Pivot-Pajot; A Kerjean; M Hazzouri; R Pelletier; M Péoc'h; B Sèle; S Khochbin; S Rousseaux
Journal:  Mol Hum Reprod       Date:  2003-12       Impact factor: 4.025

View more
  11 in total

Review 1.  Epigenetic Risks of Medically Assisted Reproduction.

Authors:  Romualdo Sciorio; Nady El Hajj
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

2.  PRSS50 is a testis protease responsible for proper sperm tail formation and function.

Authors:  Jason M Scovell; Juan C Bournat; Adam T Szafran; Minerva Solis; Joshua Moore; Armando Rivera; Ching H Chen; Jason Zhang; Nathan Wilken; Abhishek Seth; Carolina J Jorgez
Journal:  Development       Date:  2021-04-16       Impact factor: 6.868

Review 3.  The Role of Exosomal Epigenetic Modifiers in Cell Communication and Fertility of Dairy Cows.

Authors:  Pevindu Abeysinghe; Natalie Turner; Isabella Morean Garcia; Eman Mosaad; Hassendrini N Peiris; Murray D Mitchell
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

Review 4.  Genetic testing for men with infertility: techniques and indications.

Authors:  Daniel L Pelzman; Kathleen Hwang
Journal:  Transl Androl Urol       Date:  2021-03

5.  A novel posttranslational modification of histone, H3 S-sulfhydration, is down-regulated in asthenozoospermic sperm.

Authors:  Qi Qi; Hongjie Pan; Ning Jiang; Meixin Zhang; Shenfei Sun; Xiaofeng Wan; Fangxi Zhang; Lingling Zhang; Hua Diao; Jian Wang; Runsheng Li
Journal:  J Assist Reprod Genet       Date:  2021-10-18       Impact factor: 3.412

Review 6.  Contemporary Use of ICSI and Epigenetic Risks to Future Generations.

Authors:  Romualdo Sciorio; Sandro C Esteves
Journal:  J Clin Med       Date:  2022-04-11       Impact factor: 4.964

7.  Underestimated Aspects in Male Infertility: Epigenetics is A New Approach in Men with Obesity or Diabetes: A Review.

Authors:  Maryam Jazayeri; Alireza Alizadeh; Mohammadali Sadighi; Poopak Eftekhari-Yazdi; Mohsen Sharafi; Abdolhossein Shahverdi
Journal:  Int J Fertil Steril       Date:  2022-08-21

Review 8.  Lack of trusted diagnostic tools for undetermined male infertility.

Authors:  Swati Pandruvada; Rachel Royfman; Tariq A Shah; Puneet Sindhwani; James M Dupree; Samantha Schon; Tomer Avidor-Reiss
Journal:  J Assist Reprod Genet       Date:  2021-01-02       Impact factor: 3.412

9.  CircRNA Role and circRNA-Dependent Network (ceRNET) in Asthenozoospermia.

Authors:  Francesco Manfrevola; Teresa Chioccarelli; Gilda Cobellis; Silvia Fasano; Bruno Ferraro; Carolina Sellitto; Giovanni Marella; Riccardo Pierantoni; Rosanna Chianese
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-10       Impact factor: 5.555

10.  Untargeted histone profiling during naive conversion uncovers conserved modification markers between mouse and human.

Authors:  Laura De Clerck; Jasin Taelman; Mina Popovic; Sander Willems; Margot Van der Jeught; Björn Heindryckx; Petra De Sutter; Hendrik Marks; Dieter Deforce; Maarten Dhaenens
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.